Cargando…
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
Overactive bladder (OAB) is a difficult condition to live with and is very costly to the community. OAB affects 16% of the adult population and rises with increasing age. We describe the necessary steps in evaluation and behavioral therapy prior to initiating medical therapy. There are several medic...
Autores principales: | Chughtai, Bilal, Levin, Robert, De, Elise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682382/ https://www.ncbi.nlm.nih.gov/pubmed/18982920 |
Ejemplares similares
-
Treatment of overactive bladder in the aging population: focus on darifenacin
por: Jha, Swati, et al.
Publicado: (2006) -
Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy
por: Zinner, N, et al.
Publicado: (2008) -
Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin
por: Kay, G G, et al.
Publicado: (2008) -
A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder
por: Chancellor, M B, et al.
Publicado: (2008) -
An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
por: Athanasopoulos, Anastasios, et al.
Publicado: (2011)